Upgrade to SI Premium - Free Trial

Barclays Reiterates Overweight Rating on AstraZeneca (AZN:LN) (AZN)

June 30, 2026 4:24 AM
Barclays analyst James Gordon ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Intl Ratings